FDA Drug Application (021937) for ATRIPLA by GILEAD

Back to FDA Applications sponsored by GILEAD

Application Number021937
Product Number001
FormTABLET;ORAL
Dosage600MG;200MG;300MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameATRIPLA
Active IngredientEFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Active IngredientCount
List of drugs with Active Ingredient EFAVIRENZ11
List of drugs with Active Ingredient EMTRICITABINE12
List of drugs with Active Ingredient TENOFOVIR DISOPROXIL FUMARATE15


Back to FDA Applications sponsored by GILEAD